Literature DB >> 22871894

The great myth of office blood pressure measurement.

Martin G Myers1.   

Abstract

Clinical practice guidelines have traditionally recommended manual blood pressure (BP) measurement in the office setting as the standard method for diagnosing hypertension. In reality, manual BP in routine clinical practice is relatively inaccurate, over-diagnoses hypertension by provoking office-induced increases in BP and correlates poorly with both the awake ambulatory BP and target organ damage. The most recent guidelines recommend 24-h ambulatory BP and home BP for diagnosing hypertension. The advent of automated office BP (AOBP) represents a third alternative to conventional manual BP measurement, one that maintains the role of office BP readings in the diagnosis and management of hypertension. AOBP has three basic principles: multiple readings taken using a fully automated sphygmomanometer with the patient resting quietly alone. AOBP eliminates office-induced hypertension such that the cut-point for a normal AOBP is the same as for the awake ambulatory BP and home BP. As compared to routine manual office BP, AOBP provides more accurate BP readings, is more consistent during repeated office visits and in different settings and correlates better with both the awake ambulatory BP and target organ damage. The advantages of AOBP over manual BP measurement support its use in routine clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 22871894     DOI: 10.1097/HJH.0b013e3283577b05

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  32 in total

1.  Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update.

Authors:  Yazid N Al Hamarneh; Sherilyn K D Houle; Raj Padwal; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2016-10-06

2.  Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus.

Authors: 
Journal:  J Hum Hypertens       Date:  2017-04-13       Impact factor: 3.012

3.  History and Justification of a National Blood Pressure Measurement Validated Device Listing.

Authors:  Jordana B Cohen; Raj S Padwal; Michael Gutkin; Beverly B Green; Michael J Bloch; F Wilford Germino; Domenic A Sica; Anthony J Viera; Benjamin M Bluml; William B White; Sandra J Taler; Steven Yarows; Daichi Shimbo; Raymond R Townsend
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 4.  Prevention and Control of Hypertension: JACC Health Promotion Series.

Authors:  Robert M Carey; Paul Muntner; Hayden B Bosworth; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2018-09-11       Impact factor: 24.094

5.  Experts Provide a Glimpse of the New Post-SPRINT Era of Hypertension.

Authors:  Susan L Worley
Journal:  P T       Date:  2017-02

Review 6.  Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials.

Authors:  Yi Chen; Lei Lei; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2018-07-18

7.  Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives.

Authors:  Katrina Mountfort; Felix Mahfoud; Roland Schmieder; Justin Davies; David E Kandzari; Joachim Weil; Robert Whitbourn
Journal:  Interv Cardiol       Date:  2013-08

Review 8.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

9.  Unattended automated office blood pressure measurement: Time efficiency and barriers to implementation/utilization.

Authors:  John Doane; Michael Flynn; Marcus Archibald; Dominick Ramirez; Molly B Conroy; Barry Stults
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-03-09       Impact factor: 3.738

10.  Office blood pressure is lower than awake ambulatory blood pressure at lower targets for treatment.

Authors:  Martin G Myers; Janusz Kaczorowski
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.